Search

Author/Creator Green, Richard M

1. Correlation of commercially available quantitative MGMT (O-6-methylguanine-DNA methyltransferase) promoter methylation scores and GBM patient survival. Issue 3 (8th August 2018)

Authors:
Dovek, Laura; Nguyen, Nhung T; Ozer, Byram H; Li, Ning; Elashoff, Robert M; Green, Richard M; Liau, Linda; Nghiemphu, P Leia; Cloughesy, Timothy F; Lai, Albert
Journal:
Neuro-oncology practice
Issue:
Volume 6:Issue 3(2019)
Page Start:
194
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. HRD1‐ERAD controls production of the hepatokine FGF21 through CREBH polyubiquitination. (2nd November 2018)

Authors:
Wei, Juncheng; Chen, Lu; Li, Fei; Yuan, Yanzhi; Wang, Yajun; Xia, Wanjun; Zhang, Yuehui; Xu, Yuanming; Yang, Zhao; Gao, Beixue; Jin, Chaozhi; Melo‐Cardenas, Johanna; Green, Richard M; Pan, Hui; Wang, Jian; He, Fuchu; Zhang, Kezhong; Fang, Deyu
Journal:
EMBO journal
Issue:
Volume 37:Number 22(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prognostic value of O6-methylguanine-DNA methyltransferase methylation in isocitrate dehydrogenase mutant gliomas. Issue 1 (1st March 2022)

Authors:
Lam, Keng; Eldred, Blaine S C; Kevan, Bryan; Pianka, Sean; Eldred, Brittany A; Zapanta Rinonos, Serendipity; Yong, William H; Liau, Linda M; Nghiemphu, Phioanh L; Cloughesy, Timothy F; Green, Richard M; Lai, Albert
Journal:
Neuro-oncology advances
Issue:
Volume 4:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗